LCAT deficiency promotes hepatocellular carcinoma progression and lenvatinib resistance by promoting triglyceride catabolism and fatty acid oxidation
Min Xu, Peiyi Xie, Shaoqing Liu, Xukang Gao, Shiguang Yang, Zhiqiu Hu, Yue Zhao, Yong Yi, Qiongzhu Dong, Christiane J. Bruns, Xiaoni Kong, Mien‐Chie Hung, Ning Ren, Chenhao Zhou
Topics & Concepts
LenvatinibHepatocellular carcinomaCatabolismTriglycerideInternal medicineBeta oxidationEndocrinologyCancer researchMedicineChemistryBiologyBiochemistryMetabolismCholesterolSorafenibCancer, Lipids, and MetabolismCancer, Hypoxia, and MetabolismLiver Disease Diagnosis and Treatment